Literature DB >> 18056651

Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry.

Yunsen Li1, Susann Teneberg, Prakash Thapa, Albert Bendelac, Steven B Levery, Dapeng Zhou.   

Abstract

Glycosphingolipids serve as ligands for receptors involved in signal transduction and immune recognition, as exemplified by isoglobotrihexosylceramide, an antigenic ligand for T cell receptors. Mechanistic studies on the regulation of isoglobotrihexosylceramide require biochemical measurement of its lysosomal precursor, isoglobotetraglycosylceramide. It remains a challenge to distinguish between complex tetraglycosylceramide glycosphingolipid isomers with the same sugar components but diverse internal linkages. Here we established a simple and sensitive method to separate globo- and isoglobotetraglycosylceramide by MS5 ion trap mass spectrometry, and report the identification of isoglobotetraglycosylceramide in a CHO cell line transfected by iGb3 synthase, as well as in human thymus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056651     DOI: 10.1093/glycob/cwm129

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  28 in total

1.  Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.

Authors:  Xingguang Liu; Peng Zhang; Yunkai Zhang; Zheng Wang; Sheng Xu; Yingke Li; Wanwan Huai; Qingqing Zhou; Xiang Chen; Xi Chen; Nan Li; Peng Wang; Yunsen Li; Xuetao Cao
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

2.  Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells.

Authors:  Alexandre Darmoise; Susann Teneberg; Lauriane Bouzonville; Roscoe O Brady; Michael Beck; Stefan H E Kaufmann; Florian Winau
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

Review 3.  Harnessing invariant NKT cells in vaccination strategies.

Authors:  Vincenzo Cerundolo; Jonathan D Silk; S Hajar Masri; Mariolina Salio
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

Review 4.  CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.

Authors:  Jennifer L Matsuda; Thierry Mallevaey; James Scott-Browne; Laurent Gapin
Journal:  Curr Opin Immunol       Date:  2008-05-22       Impact factor: 7.486

Review 5.  Optimizing NKT cell ligands as vaccine adjuvants.

Authors:  Leandro J Carreño; Shalu Sharma Kharkwal; Steven A Porcelli
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

6.  Enzymatic synthesis of Gb3 and iGb3 ceramides.

Authors:  Dietlind Adlercreutz; Joel T Weadge; Bent O Petersen; Jens Ø Duus; Norman J Dovichi; Monica M Palcic
Journal:  Carbohydr Res       Date:  2010-02-13       Impact factor: 2.104

Review 7.  NKT cell immune responses to viral infection.

Authors:  Marlowe S Tessmer; Ayesha Fatima; Christophe Paget; Francois Trottein; Laurent Brossay
Journal:  Expert Opin Ther Targets       Date:  2009-02       Impact factor: 6.902

8.  Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Wiebke Storck; Lena Radamm; Petra Hoffmann; Martina Bielaszewska; Andreas Bauwens; Christoph Cichon; M Alexander Schmidt; Michael Mormann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2012-12-17       Impact factor: 5.922

Review 9.  Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Lan Wu; Luc Van Kaer
Journal:  Expert Rev Vaccines       Date:  2008-12       Impact factor: 5.217

10.  The alphaGal epitope of the histo-blood group antigen family is a ligand for bovine norovirus Newbury2 expected to prevent cross-species transmission.

Authors:  Maha Zakhour; Nathalie Ruvoën-Clouet; Annie Charpilienne; Brigitte Langpap; Didier Poncet; Thomas Peters; Nicolai Bovin; Jacques Le Pendu
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.